Interplay of androgens, microbiota and immunoregulation in lupus
狼疮中雄激素、微生物群和免疫调节的相互作用
基本信息
- 批准号:9330062
- 负责人:
- 金额:$ 43.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAgonistAndrogen ReceptorAndrogensAutoimmune DiseasesCastrationCell physiologyComplexCytoprotectionDataDefectDendritic CellsDevelopmentDiabetes MellitusDiseaseEnvironmentEstrogensExhibitsFecesFemaleGonadal Steroid HormonesHealthHumanImmune responseImmune systemImmunologicsIn VitroInbred NOD MiceIncidenceInflammatoryInsulin-Dependent Diabetes MellitusIntestinesKnowledgeLeadLinkLupusMediatingMen&aposs RoleMicrobiological TechniquesModelingMusPathogenesisPhytolPlayPrevention strategyProductionPropertyPubertyRXRReceptor SignalingRegulatory T-LymphocyteRoleSeverity of illnessSymbiosisSystemic Lupus ErythematosusTechniquesTherapeuticTreatment ProtocolsTretinoinVolatile Fatty AcidsWomanautoreactivitybasecommensal microbesdisorder preventionfecal transplantationgender differencegut microbiotaimmunoregulationimprintin vivoinnovationmalemenmetabolomemetabolomicsmicrobiotamortalitymouse modelnext generation sequencingnovelnovel therapeuticspublic health relevancesex
项目摘要
DESCRIPTION (provided by applicant): Resubmission Systemic lupus erythematosus (SLE) is much more prevalent in females than males in humans, and in the (NZBxNZW)F1 (BWF1) mouse model of lupus. Although estrogens can exacerbate disease in females, considerable evidence suggests that androgens play a critical role in protecting males from lupus in both humans and mice. The gut microbiota is now thought to play a major role in host health and disease, and microbiota dysbiosis is associated with development of autoimmune diseases. Interestingly, androgens can have a significant impact on the microbiota and vice versa. Recent studies in a mouse model of type 1 diabetes (T1D) suggest that the microbiota and androgens collaborate, in what is now being referred to as the "microgenderome", to protect male mice from disease via currently unknown mechanisms. However, little is known about the relationship between androgens and the microbiota in lupus. In preliminary studies, we have found that both the microbiota composition and metabolomic profile differ significantly between mature female and male BWF1 mice, and transfer of male microbiota to female BWF1 mice protects female recipients from disease, and significantly enhances survival. These data suggest that the male environment confers protective properties on the microbiota by altering microbiota composition and/or metabolome. Metabolites from commensal bacteria have been found to induce Treg differentiation both directly and through DC. The gut CD103+ dendritic cells (CD103DC) are highly tolerogenic, and generate regulatory T cells in the periphery that can control systemic immune responses. Our preliminary data showing sex-based differences in CD103DC function, and the requirement for CD103+ cells for protection in male BWF1 mice strongly support the notion that CD103DC function as a critical link between the male gut microbiota and the immune response, and may, therefore, play an important role in protecting BWF1 male mice from disease. Moreover, preliminary analysis of the microbiota metabolome has identified a metabolite that is increased in male BWF1 mice that may have an impact CD103DC function. We, therefore, hypothesize that the androgen-modified male microbiota and its metabolites protect against lupus by acting through the gut CD103DC. This novel hypothesis will be addressed in lupus-prone BWF1 mice by 1) examining the impact of androgens on the gut microbiota and its metabolites; 2) exploring the role of male microbiota and its metabolites in protection from disease; and 3) determining the role that CD103DC play in male microbiota- mediated protection from disease. The proposed project will fill the gaps in our knowledge about the role of the androgen-gut microbiota relationship in immunoregulation and lupus, and will lead to the development of novel therapeutic strategies using the microbiota and/or its metabolites for the treatment of lupus and other autoimmune diseases.
描述(由申请人证明):重新提出系统性的红斑鱼(SLE)在人类中更为普遍。现在,在人类和小鼠中保护狼疮的角色在宿主健康和疾病中。 。狼疮中的雄性生物群和雄性bwf1小鼠的转移可击败冰,并通过改变微生物群的特性,从而显着增强了疾病。直接通过DC进行区分。在雄性BWF1小鼠中,CD103DC充当雄性肠道微生物群弹药的关键联系,因此,在保护BWF1雄性小鼠免受疾病的影响方面可能起重要作用。在雄性BWF1小鼠中,可能会在lupus cd103dc中探索雄激素改性的雄性微生物ATS代谢物来防止狼疮的雄性微生物ATS代谢物。 2)LE Microbiota及其在保护疾病中的代谢物;它的代谢物用于治疗狼疮和其他自身免疫性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHELE M KOSIEWICZ其他文献
MICHELE M KOSIEWICZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHELE M KOSIEWICZ', 18)}}的其他基金
Interplay of androgens, microbiota and immunoregulation in lupus
狼疮中雄激素、微生物群和免疫调节的相互作用
- 批准号:
8969464 - 财政年份:2015
- 资助金额:
$ 43.19万 - 项目类别:
Interplay of androgens, microbiota and immunoregulation in lupus
狼疮中雄激素、微生物群和免疫调节的相互作用
- 批准号:
9766076 - 财政年份:2015
- 资助金额:
$ 43.19万 - 项目类别:
Interplay of androgens, microbiota and immunoregulation in lupus
狼疮中雄激素、微生物群和免疫调节的相互作用
- 批准号:
9068816 - 财政年份:2015
- 资助金额:
$ 43.19万 - 项目类别:
Analyzing and modulating immunoregulatory defects in autoimmune disease
分析和调节自身免疫性疾病的免疫调节缺陷
- 批准号:
7166069 - 财政年份:2006
- 资助金额:
$ 43.19万 - 项目类别:
Analyzing and modulating immunoregulatory defects in autoimmune disease.
分析和调节自身免疫性疾病的免疫调节缺陷。
- 批准号:
7336341 - 财政年份:2006
- 资助金额:
$ 43.19万 - 项目类别:
Analyzing and modulating immunoregulatory defects in autoimmune disease
分析和调节自身免疫性疾病的免疫调节缺陷
- 批准号:
7036311 - 财政年份:2006
- 资助金额:
$ 43.19万 - 项目类别:
Analyzing and modulating immunoregulatory defects in autoimmune disease.
分析和调节自身免疫性疾病的免疫调节缺陷。
- 批准号:
7559008 - 财政年份:2006
- 资助金额:
$ 43.19万 - 项目类别:
Analyzing and modulating immunoregulatory defects in autoimmune disease.
分析和调节自身免疫性疾病的免疫调节缺陷。
- 批准号:
7751340 - 财政年份:2006
- 资助金额:
$ 43.19万 - 项目类别:
Sex-based differences in regulatory T cell responses
调节性 T 细胞反应的性别差异
- 批准号:
6759286 - 财政年份:2002
- 资助金额:
$ 43.19万 - 项目类别:
Sex-based differences in regulatory T cell responses
调节性 T 细胞反应的性别差异
- 批准号:
6626302 - 财政年份:2002
- 资助金额:
$ 43.19万 - 项目类别:
相似国自然基金
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境激素壬基酚对变应性鼻炎的影响及其对GPER特异性激动剂G-1在变应性鼻炎治疗作用中的干扰机制研究
- 批准号:82000963
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
五羟色胺2C受体激动剂对2型糖尿病小鼠β细胞功能的影响及机制研究
- 批准号:81803644
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
cAMP信号激动剂对恶性胶质瘤血管新生和血管正常化的影响及机制研究
- 批准号:81803568
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of nigrostriatal and striatal cell subtype signaling in behavioral impairments related to schizophrenia
黑质纹状体和纹状体细胞亚型信号传导在精神分裂症相关行为障碍中的作用
- 批准号:
10751224 - 财政年份:2024
- 资助金额:
$ 43.19万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 43.19万 - 项目类别:
The role of core circadian regulator Bmal1 in axonal regeneration and nerve repair
核心昼夜节律调节因子 Bmal1 在轴突再生和神经修复中的作用
- 批准号:
10677932 - 财政年份:2023
- 资助金额:
$ 43.19万 - 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10844877 - 财政年份:2023
- 资助金额:
$ 43.19万 - 项目类别:
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
针对创伤引起的免疫失调中训练有素的免疫力
- 批准号:
10714384 - 财政年份:2023
- 资助金额:
$ 43.19万 - 项目类别: